Nina Capital
Positioning Nina Capital at the Center of Europe’s HealthTech Innovation and Investment Dialogue
- 14+ Fund III Articles across European tech and business media
- 40 Pieces of coverage
- 2M Audience combined (UMV)
The Objective
At the beginning of the PR programme with Ballou, Nina Capital wanted to announce the launch of its Fund III, with a target close of €50m. The aim was to build the profile of the fund and Nina Capital’s founder, Dr Marta G. Zanchi, with a series of briefings in business, investment, tech, and health tech media.
The Campaign
Ballou led a targeted briefing campaign, securing interviews with a wide range of European business, investment, and health tech outlets. Following the spread of interview and Q&A coverage secured by Ballou, two LPs reached out to Nina Capital to set up meetings to discuss investing.
The Results
‘It’s truly a pleasure to be working with a team as professional and dynamic as yours. We’ve clearly chosen a partner who brings expertise and a vibrant spirit to the table, which makes collaboration all the more enjoyable. It’s the best external collaboration I’ve ever had and I’d double the budget if I could.’’
Marta G. Zanchi, founder & managing partner,
Nina Capital
The campaign successfully positioned Nina Capital and its founder, Dr Marta G. Zanchi, as key voices in Europe’s healthtech investment landscape during the launch of Fund III.
The strong media presence generated tangible investor interest, with two LPs reaching out directly after coverage to discuss potential investment in the fund.